Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

Clinical trial NCT05779917 · RECRUITING

Trial details

NCT number: NCT05779917
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreas Cancer CAR-T Cell Therapy Mesothelin Solid Tumor, Adult

Start date: 2023-03-10
Primary completion: 2029-03-10
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.